TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2014-05-15

Name: TuHURA BIOSCIENCES, INC./NV: 10-Q filed 2014-05-15
Creator: TuHURA BIOSCIENCES, INC./NV

What TuHURA BIOSCIENCES, INC./NV reported in its quarterly report filed 2014-05-15 (fiscal Q1 2014): 16 published measures, 49 facts as tagged in accession 0001013762-14-000563.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-05-15
Fiscal period: fiscal Q1 2014
Accession: 0001013762-14-000563 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TuHURA BIOSCIENCES, INC./NV filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-03-31	3,754,153	USD
At 2013-12-31	4,318,748	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-03-31	6,814,452	USD
At 2013-12-31	5,136,726	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-03-31	-3,060,299	USD
At 2013-12-31	-817,978	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-03-31	3,474,150	USD
At 2013-12-31	4,136,803	USD
At 2013-03-31	7,532,835	USD
At 2012-12-31	17,782	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-3,198,607	USD	90
2010-04-07 to 2014-03-31	-15,331,429	USD	1455
2013-01-01 to 2013-03-31	-7,405,319	USD	90

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	620,074	USD	90
2010-04-07 to 2014-03-31	4,024,311	USD	1455
2013-01-01 to 2013-12-31	2,146,766	USD	365
2013-01-01 to 2013-03-31	272,902	USD	90
2012-01-01 to 2012-12-31	1,130,240	USD	366

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	2,015	USD	90
2010-04-07 to 2014-03-31	39,489	USD	1455
2013-01-01 to 2013-03-31	1,955	USD	90

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-03-31	440,211	USD
At 2013-12-31	249,487	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	1,585,792	USD	90
2010-04-07 to 2014-03-31	11,988,044	USD	1455
2013-01-01 to 2013-03-31	1,552,324	USD	90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	618,869	USD	90
2010-04-07 to 2014-03-31	5,604,809	USD	1455
2013-01-01 to 2013-12-31	568,725	USD	365
2013-01-01 to 2013-03-31	631,947	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit
At 2014-03-31	32,082,132	shares
At 2013-12-31	31,534,819	shares
At 2012-12-31	13,050,000	shares
At 2010-12-31	8,256,250	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2014-03-31	21,178	USD
At 2013-12-31	21,178	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-3,198,607	USD	90
2010-04-07 to 2014-03-31	-15,310,251	USD	1455
2013-01-01 to 2013-03-31	-7,405,319	USD	90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	966,923	USD	90
2010-04-07 to 2014-03-31	6,383,235	USD	1455
2013-01-01 to 2013-12-31	1,578,041	USD	365
2013-01-01 to 2013-03-31	920,377	USD	90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-1,612,815	USD	90
2010-04-07 to 2014-03-31	-3,343,385	USD	1455
2013-01-01 to 2013-03-31	-5,852,995	USD	90

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2010-04-07 to 2014-03-31	102,070	USD	1455
2010-09-01 to 2010-09-08	26,989	USD	8
2010-08-01 to 2010-08-27	68,414	USD	27

Inspect the source

Entity: TuHURA BIOSCIENCES, INC./NV / CIK 0001498382
Captured: 2026-09-20T09:11:11.339Z
SEC response SHA-256: cbfb2cda3307f7af300be1fc56e9d85ca5186f16e46a189d675574c95ee74f5c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001498382.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))